Oncologist
Academic research and publications
- Plasma-Based microRNA Expression Analysis in Advanced Stage NSCLC Patients Treated with Nivolumab, 2022
- Prognostic role of microRNAs in breast cancer: A systematic review, 2019
- A Prognostic Role for Circulating microRNAs Involved in Macrophage Polarization in Advanced Non-Small Cell Lung Cancer, 2021
- Evaluation of pre-mir-34a rs72631823 single nucleotide polymorphism in triple negative breast cancer: A case-control study, 2018
- MicroRNAs Regulating Tumor Immune Response in the Prediction of the Outcome in Patients With Breast Cancer, 2021
- Evaluation of MET T1010I and MET rs40239 single-nucleotide polymorphisms in triple-negative breast cancer: a case-control study, 2019
- Lenalidomide with low- or intermediate-dose dexamethasone in patients with relapsed or refractory myeloma, 2016
- TLR4/TIRAP polymorphisms are associated with progression and survival of patients with symptomatic myeloma, 2015
- Prognostic significance of miR-34 rs4938723 T > C polymorphism in triple negative breast cancer patients, 2019
- PD-L1 Gene Polymorphisms rs822336 G>C and rs822337 T>A: Promising Prognostic Markers in Triple Negative Breast Cancer Patients, 2022
- Long-term outcomes of primary systemic light chain (AL) amyloidosis in patients treated upfront with bortezomib or lenalidomide and the importance of risk adapted strategies, 2015
- The Prognostic Role of Protein Expression in Pregnancy- Associated Breast Cancer: A Literature Review, 2020
- Report from the Front: a Glimpse at Breast Cancer Research in Lowand Middle-Income Countries, 2019
- Oral Toxicities in Cancer Patients, Who Receive Immunotherapy: A Case Series of 24 Patients , 2023
- ΜΕΛΕΤΗ ΜΟΝΗΡΩΝ ΠΟΛΥΜΟΡΦΙΣΜΩΝ ΣΤΟΝ ΤΡΙΠΛΑ ΑΡΝΗΤΙΚΟ ΚΑΡΚΙΝΟ ΤΟΥ ΜΑΣΤΟΥ, ΕΚΠΑ (2019)
- Prognostic role of immune checkpoints mRNA expression in peripheral blood of non-small cell lung cancer patients treated with immune checkpoint inhibitors, 2022
- Monitoring of PD-L1 expression on circulating immune cells of patients with small cell lung cancer (SCLC) receiving first- line treatment: Prognostic implications, 2022
Useful Links
-
Nearby Areas
-
Relevant Services
-
Health Articles
-
Nearby Hospitals
Are you a new user?
Register for free
Create a new password
Your data is in good hands
doctoranytime takes your health as well as your data protection very seriously!
In order to ensure you that:
- you will continue to get the best possible treatment from the affiliated doctors and diagnostic centers
- you will continue to book your appointments easily and quickly by having at the same time the right of evaluation
- we will be able to contact you immediately in case of a change in your appointment
- you will continue to receive our newsletter and health suggestions that may interest you
it is essential for us to collect and process your personal data to the extent that you allow.
For this reason, we would like to inform you that we take all the necessary measures in order to protect your personal data, according to the New European General Data Protection Regulation (“GDPR”), the terms of the doctoranytime Privacy Policy (that you can read in detail here) and the law requirements.
If you have any questions regarding your privacy protection by doctoranytime or in case you wish to exercise your GDPR rights (information, access, correction, deletion, limitation of processing, portability of your data, objection and right to lodge a complaint with the Personal Data Protection Authority) you can contact the Data Protection Officer of doctoranytime on: [email protected].
Congratulations!!
Your registration has completed.